NDC 65862-391 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC65862-391

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Aurobindo Pharma Limited
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (6)

Package NDCDescriptionSince
65862-391-011 BLISTER PACK in 1 CARTON (65862-391-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMar 24, 2021
65862-391-02100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-02)Apr 12, 2024
65862-391-05500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-05)Apr 12, 2024
65862-391-103 BLISTER PACK in 1 CARTON (65862-391-10) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKApr 12, 2010
65862-391-3030 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-30)Apr 12, 2010
65862-391-666000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-66)Apr 12, 2010

Other Ondansetron products